Stories from people navigating gastroesophageal reflux disease — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories
Innovation & Devices
The Class I recall covers Bravo CF delivery devices that may not attach or release the esophageal pH capsule as intended. Gastroenterology services should review inventory, prior procedures and testing alternatives.
Rayan Salih · October 12, 2026 · 6 min
Clinical Briefs
FDA approval of RefluxStop requires a prospective study of 200 patients with GERD, reflecting unresolved questions about long-term implant safety, effectiveness and durability.
Dr. Abu Bakar · 6 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.